Chlormadinone acetate versus micronized progesterone in the sequential combined hormone replacement therapy of the menopause

被引:18
作者
Pélissier, C
Maroni, M
Yaneva, H
Brin, S
Peltier-Pujol, F
Jondet, M
机构
[1] Hop Paris, F-75016 Paris, France
[2] Hoechst Marion Roussel, Labs Solymes, F-92910 Paris, France
[3] Cabinet Anat & Cytol Pathol, F-75014 Paris, France
关键词
chlormadinone acetate; progesterone; endometrial biopsy; bleeding pattern; lipid profile; hormone replacement therapy; postmenopausal women;
D O I
10.1016/S0378-5122(01)00170-0
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: The efficacy and safety of chlormadinone acetate (CA) versus micronized progesterone (P) were assessed in non-hysterectomized postmenopausal women. Materials and methods: This was a multicenter, randomized, parallel group study with a 6-month double-blind period followed by a 12-month open period. Patients were randomized to receive every month during 18 months percutaneous 17 beta -estradiol (E-2) 1.5 mg/day from Day 1 to 24 of treatment cycle, combined from Day I I to 24 to either CA 10 mg/day (n = 167) or P 200 mg/day (n = 169). Endometrial biopsy (EB, main analysis criterion) was performed at baseline, and at Day 18-24 of the 6th and 18th cycles. Results: At Month 6, EB did not evidence any hyperplasia. EB were inadequate for assessment in 24.5% and 47.5% of patients in the CA and MP groups, respectively. CA was found to be as protective as P (96.3% and 92.0% of success). However, the hormonal status of the endometrium differed (P < 0.001): a secretory endometrium was found in 81.5% of the CA patients, compared to 50.7% in the P group. These transformations resulted in predictable, cyclic bleeding in 94.5% of the CA patients, compared to only 62.3% of the P patients (P = 0.0001). Unscheduled bleeding, spotting and/or metrorrhagia, were more frequent under P than under CA (17.9% and 13.7%, respectively). The beneficial effects on hot flushes were more important in the CA group than in the P (P < 0.001). At Month 18, the biopsy and clinical results were similar to those obtained at Month 6. The safety profile, particularly the lipid one, was similar in both groups, except for drowsiness and dizziness, which were significantly more frequent under P than under CA. Conclusion: The progestative effects of CA on the endometrium. and on menopause-related symptoms were at least as good as those of P. Moreover, CA resulted more often than P in secretory effects, and in satisfying bleeding patterns. (C) 2001 Published by Elsevier Science Ireland Ltd.
引用
收藏
页码:85 / 94
页数:10
相关论文
共 34 条
[1]  
ARCHER DF, 1994, OBSTET GYNECOL, V83, P686
[2]   ENDOMETRIAL MORPHOLOGY IN ASYMPTOMATIC POSTMENOPAUSAL WOMEN [J].
ARCHER, DF ;
MCINTYRESELTMAN, K ;
WILBORN, WW ;
DOWLING, EA ;
CONE, F ;
CREASY, GW ;
KAFRISSEN, ME .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 165 (02) :317-322
[3]  
BURCH DJ, 1995, BRIT J OBSTET GYNAEC, V102, P143
[4]   DOSE-RESPONSE EVALUATION OF CYCLIC ESTROGEN GESTAGEN IN POST-MENOPAUSAL WOMEN - PLACEBO-CONTROLLED TRIAL OF ITS GYNECOLOGIC AND METABOLIC ACTIONS [J].
CHRISTENSEN, MS ;
HAGEN, C ;
CHRISTIANSEN, C ;
TRANSBOL, I .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 144 (08) :873-879
[5]   HORMONAL REPLACEMENT THERAPY AND THE SKELETAL SYSTEM [J].
CHRISTIANSEN, C ;
RIIS, BJ .
MATURITAS, 1990, 12 (03) :247-257
[6]   5 YEARS WITH CONTINUOUS COMBINED ESTROGEN PROGESTOGEN THERAPY - EFFECTS ON CALCIUM-METABOLISM, LIPOPROTEINS, AND BLEEDING PATTERN [J].
CHRISTIANSEN, C ;
RIIS, BJ .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (12) :1087-1092
[7]   Hormone replacement therapy: Clinical benefits and side-effects [J].
deLignieres, B .
MATURITAS, 1996, 23 :S31-S36
[8]  
*EUR MEN SOC, 1996, C EUR CONS MEN MONTR
[9]   Endometrial histology and bleeding patterns in post-menopausal women taking sequential, combined estradiol and dydrogesterone [J].
Ferenczy, A ;
Gelfand, MM .
MATURITAS, 1997, 26 (03) :219-226
[10]  
FRASER DI, 1991, FERTIL STERIL, V53, P460